[1]
Haresh Ram et al. 2025. In Silico Evaluation of (3R,4R)-Piperidine-Pyrrolopyrimidine Derivatives as Potential Anticancer Agents Targeting Topoisomerase I/II, Bcl-2, and HDAC2. International Journal of Scientific Research in Science, Engineering and Technology. 12, 4 (Jul. 2025), 41–47. DOI:https://doi.org/10.32628/IJSRSET2512407.